Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 11:16 am Sale | 2023-09-30 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 2,271,925 2.310% | -11,717,507 (-83.76%) | Filing History |
| 2023-05-10 09:16 am Purchase | 2023-04-30 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 13,989,432 14.240% | 8,053,973 (+135.69%) | Filing History |
| 2023-04-19 5:15 pm Purchase | 2023-04-13 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 15,071,096 14.900% | 2,077,208 (+15.99%) | Filing History |
| 2023-03-22 4:15 pm Purchase | 2023-03-16 | 13G | Fate Therapeutics, Inc. FATE | Millennium Management LLC | 1,696,431 1.700% | 1,696,431 (New Position) | Filing History |
| 2023-03-10 07:59 am Purchase | 2023-02-28 | 13G | Fate Therapeutics, Inc. FATE | The Vanguard Group | 9,936,042 10.120% | 1,963,491 (+24.63%) | Filing History |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Fate Therapeutics, Inc. FATE | Capital World Investors | 5,591,517 5.800% | 5,591,517 (New Position) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Fate Therapeutics, Inc. FATE | The Vanguard Group | 7,972,551 8.200% | 296,764 (+3.87%) | Filing History |
| 2023-02-03 09:54 am Purchase | 2022-12-31 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 5,935,459 6.110% | 5,935,459 (New Position) | Filing History |
| 2023-01-06 12:23 pm Purchase | 2022-12-31 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 9,725,895 10.000% | 2,665,343 (+37.75%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Fate Therapeutics, Inc. FATE | The Vanguard Group | 7,675,787 8.040% | 897,200 (+13.24%) | Filing History |
| 2022-02-09 2:37 pm Sale | 2021-12-31 | 13G | Fate Therapeutics, Inc. FATE | ARK Investment Management LLC | 10,312,167 10.800% | -478,256 (-4.43%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 7,060,552 7.400% | 389,011 (+5.83%) | Filing History |
| 2021-10-12 09:25 am Sale | 2021-10-08 | 13G | Fate Therapeutics, Inc. FATE | FMR LLC | 2,249,450 2.363% | -5,355,454 (-70.42%) | Filing History |
| 2021-09-10 2:48 pm Purchase | 2021-08-31 | 13G | Fate Therapeutics, Inc. FATE | ARK Investment Management LLC | 10,790,423 11.340% | 10,790,423 (New Position) | Filing History |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Fate Therapeutics, Inc. FATE | The Vanguard Group | 6,778,587 7.770% | 6,778,587 (New Position) | Filing History |
| 2021-02-08 10:21 am Purchase | 2021-02-05 | 13G | Fate Therapeutics, Inc. FATE | FMR LLC | 7,604,904 8.716% | 719,321 (+10.45%) | Filing History |
| 2021-02-03 12:34 pm Unchanged | 2020-12-31 | 13G | EVO Payments, Inc. EVOP | VICTORY CAPITAL MANAGEMENT INC | 2,091,280 2.400% | 0 (Unchanged) | Filing History |
| 2021-02-03 10:51 am Sale | 2020-12-31 | 13G | EVO Payments, Inc. EVOP | VICTORY CAPITAL MANAGEMENT INC | 2,091,280 2.400% | -2,137,874 (-50.55%) | Filing History |
| 2021-01-29 09:57 am Purchase | 2020-12-31 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 6,671,541 7.600% | 878,854 (+15.17%) | Filing History |
| 2021-01-12 4:18 pm Purchase | 2021-01-08 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 12,993,888 14.100% | 332,152 (+2.62%) | Filing History |